Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mast Cell Activation Disorders × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 479 Neoplasms 418 Carcinoma, Non-Small-Cell Lung 367 Prostatic Neoplasms 316 Lung Neoplasms 243 Colorectal Neoplasms 233 Neoplasm Metastasis 195 Leukemia, Myeloid, Acute 184 Multiple Myeloma 180 Ovarian Neoplasms 164 Melanoma 162 Pancreatic Neoplasms 139 Brain Neoplasms 113 Squamous Cell Carcinoma of Head and Neck 112 Recurrence 108 Carcinoma, Hepatocellular 103 Endometrial Neoplasms 100 Lymphoma 99 Glioma 99 Glioblastoma 98 Uterine Cervical Neoplasms 97 Urinary Bladder Neoplasms 97 Triple Negative Breast Neoplasms 97 Stomach Neoplasms 96 Precursor Cell Lymphoblastic Leukemia-Lymphoma 94 Carcinoma, Renal Cell 94 Lymphoma, Non-Hodgkin 83 Hematologic Neoplasms 83 Leukemia, Lymphocytic, Chronic, B-Cell 80 Myelodysplastic Syndromes 78

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06186856 2026-03-05

DATAMAST

Imagine Institute

13,000 enrolled

Mast Cell Activation Disorders, Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡